We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Ashland Inc | NYSE:ASH | NYSE | Common Stock |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.86 | 0.90% | 96.06 | 96.865 | 95.63 | 95.63 | 252,676 | 01:00:00 |
|
|
|
|
|
Delaware
(State of Incorporation or Organization)
|
|
333-211719
(Commission File Number)
|
|
81-2587835
(IRS Employer Identification No.)
|
50 E. RiverCenter Boulevard
Covington, Kentucky 41011
(Address of principal executive offices)
|
Exhibit
Number |
Description of Exhibit
|
|
2.1
|
Stock Purchase Agreement, dated April 14, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders’ representative.
|
|
2.2
|
Amendment No. 1 to the Stock Purchase Agreement, dated May 16, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders’ representative.
|
|
10.1
|
Credit Agreement, dated as of May 17, 2017, among Ashland LLC, as Borrower, The Bank of Nova Scotia, as Administrative Agent, Swing Line Lender and an L/C Issuer, each Lender and L/C Issuer party thereto and the other agents party thereto.
|
|
99.1
|
News Release issued by Ashland Global Holdings Inc., dated May 17, 2017.
|
ASHLAND GLOBAL HOLDINGS INC. | |||
(Registrant)
|
|||
May 18, 2017
|
By:
|
/s/ Peter J. Ganz | |
Peter J. Ganz | |||
Senior Vice President, General Counsel and Secretary | |||
Exhibit
Number |
Description of Exhibit
|
|
2.1
|
Stock Purchase Agreement, dated April 14, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders’ representative.
|
|
2.2
|
Amendment No. 1 to the Stock Purchase Agreement, dated May 16, 2017, by and among Ashland LLC, Pharmachem Laboratories, Inc., the holders of common stock of Pharmachem Laboratories, Inc., Dr. David Peele, and Photon SH Representative LLC, solely as the shareholders’ representative.
|
|
10.1
|
Credit Agreement, dated as of May 17, 2017, among Ashland LLC, as Borrower, The Bank of Nova Scotia, as Administrative Agent, Swing Line Lender and an L/C Issuer, each Lender and L/C Issuer party thereto and the other agents party thereto.
|
|
99.1
|
News Release issued by Ashland Global Holdings Inc., dated May 17, 2017.
|
1 Year Ashland Chart |
1 Month Ashland Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions